Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1873071Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$2.7M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#4,107
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Gerard Joseph Marek as a PI. Multi-PI records show the full award amount for context.
- 6UG3DA060053-03UG3Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder$1.9Maward amount
- 5UG3DA060053-02UG3Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder$841.3Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Gerard Joseph Marek as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardGilgamesh Pharma Inc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3083
- 2024Entered Top 25% NationallyRanked #3083
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions